NEW YORK, Nov. 16, 2016 /PRNewswire/ -- The global Prefilled Syringes market is projected to surpass USD 5.35 billion by 2021, growing with a CAGR between 9.2% and 9.5% from 2016 to 2021. Prefilled Syringes are used in administering drugs for range of diseases. Prefilled Syringes are convenient, cost-effective and safe mode of drug delivery. Increased usage of Prefilled Syringes in non-medical settings and in large clinical trials have spurred the growth of Prefilled Syringes market in recent times. Growing demand for self-administered drugs is expected to simulate industry expansion further. In addition, technological advancements in manufacturing and labelling of Prefilled Syringe is expected to augment growth over the forecast period . However, since both glass and polymer based prefilled syringes are available, manufacturers and users have to be careful in its usage as the drug might interfere with the packaging material in which might hamper the adoption and therefore growth of the Prefilled Syringes in new markets. Segments Covered:The report segments the global Prefilled Syringes market by species, application and region. The product types covered in the study include glass prefilled syringes and plastic prefilled syringes. Furthermore, on the basis of application, the market has been segmented into monoclonal antibodies, vaccines and others. The report also gives an insight about the distribution channels which includes hospitals, ambulatory surgical centres, mail order pharmacies and others. Geographic Coverage and Analysis: The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. Europe is the largest market of prefilled syringes due to extensive adoption of injectable delivery devices. The U.S. and Japan are among the major contributors to the revenue in global prefilled syringes market. North America is expected to grow at a higher CAGR during the forecast period when compared to Europe. Companies profiled:The companies covered in the report include Aniline Corporation, Baxter International, Inc., Becton, Dickinson & Company, Bespak, Gerresheimer AG, Terumo Medical Corporation, Medtronic, Nipro Corporation, Schott AG, Stevanato Group, Vetter Pharma International GmbH, West Pharmaceutical Services, Inc. and Ypsomed Holding AG. Report Highlights:The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of prefilled syringes globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and value chain analysis of prefilled syringes. Moreover, the study highlights current market trends and provides forecast from 2016 to 2021. We also have highlighted future trends in the prefilled syringes market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the prefilled syringes market to understand the present and future trends in this market and formulate their strategies accordingly. Read the full report: http://www.reportlinker.com/p04290242-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.